Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria

Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria

The majority of routinely given vaccines require two or three immunisations for full protective efficacy. Single dose vaccination has long been considered a key solution to improving the global immunisation coverage. Recent infectious disease outbreaks have further highlighted the need for vaccines...

Bibliografski detalji
Glavni autori:	Milicic, A, Rollier, C, Tang, C, Longley, R, Hill, A, Reyes-Sandoval, A
Format:	Journal article
Jezik:	English
Izdano:	Springer Nature 2017

Slični predmeti

Viral vector vaccines make memory T cells against malaria.
od: Reyes-Sandoval, A, i dr.
Izdano: (2007)

Viral vectors as vaccine platforms: Deployment in sight
od: Rollier, C, i dr.
Izdano: (2011)

Viral vectors as vaccine platforms: deployment in sight.
od: Rollier, C, i dr.
Izdano: (2011)

Tailoring a combination pre-erythrocytic malaria vaccine
od: Bauza, K, i dr.
Izdano: (2015)

A probabilistic model of pre-erythrocytic malaria vaccine combination in mice
od: Atcheson, E, i dr.
Izdano: (2019)

Pre-erythrocytic malaria vaccines: towards greater efficacy.
od: Hill, A
Izdano: (2006)

Low immunogenicity of malaria pre-erythrocytic stages can be overcome by vaccination
od: Müller, K, i dr.
Izdano: (2021)

Immunogenicity of a pre-erythrocytic-stage malaria insert ME-trap encoded by novel simian adenoviral vectors
od: Reyes-Sandoval, A, i dr.
Izdano: (2005)

Liposomes as vaccine adjuvants
od: Milicic, A, i dr.
Izdano: (2010)

Modeling combinations of pre-erythrocytic plasmodium falciparum malaria vaccines
od: Walker, A, i dr.
Izdano: (2015)

Low immunogenicity of malaria pre‐erythrocytic stages can be overcome by vaccination
od: Katja Müller, i dr.
Izdano: (2021-03-01)

Assessment of the Plasmodium falciparum pre-erythrocytic antigen UIS3 as a potential candidate for a malaria vaccine
od: Longley, R, i dr.
Izdano: (2016)

Viral vectors for malaria vaccine development.
od: Li, S, i dr.
Izdano: (2007)

CD8(+) T effector memory cells are a correlate of protection against liver-stage malaria
od: Reyes-Sandoval, A, i dr.
Izdano: (2010)

Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M
od: Venkatraman, N, i dr.
Izdano: (2017)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity.
od: Reyes-Sandoval, A, i dr.
Izdano: (2012)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity
od: Reyes-Sandoval, A, i dr.
Izdano: (2012)

CD8+ T effector memory cells protect against liver-stage malaria.
od: Reyes-Sandoval, A, i dr.
Izdano: (2011)

CD8+ T effector memory cells protect against liver-stage malaria
od: Reyes-Sandoval, A, i dr.
Izdano: (2011)

New approaches to pre-erythrocytic malaria vaccination
od: Mukhopadhyay, E
Izdano: (2021)

Screening of viral-vectored P. falciparum pre-erythrocytic candidate vaccine antigens using chimeric rodent parasites
od: Kolli, SK, i dr.
Izdano: (2021)

New vectored vaccines for malaria.
od: Hill, A, i dr.
Izdano: (2008)

Screening of viral-vectored P. falciparum pre-erythrocytic candidate vaccine antigens using chimeric rodent parasites.
od: Surendra Kumar Kolli, i dr.
Izdano: (2021-01-01)

Viral vectors as vaccine platforms: from immunogenicity to impact
od: Ewer (nee Russell), K, i dr.
Izdano: (2016)

Pre-erythrocytic malaria vaccines: RTS,S, R21, and beyond
od: Elizabeth Adrianne Hammershaimb, i dr.
Izdano: (2024-12-01)

Assessment of novel pre-erythrocytic malaria vaccines in humans
od: Venkatraman, N
Izdano: (2017)

Pre-clinical development of viral vectored transmission-blocking malaria vaccines
od: Kapulu, MC
Izdano: (2014)

Pre-clinical development and assessment of viral vectors expressing a fusion antigen of P. falciparum LSA1 and LSAP2 for efficacy against liver-stage malaria
od: Halbroth, B, i dr.
Izdano: (2019)

Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trial.
od: Hodgson, S, i dr.
Izdano: (2014)

Validation of a multiplexed immunoassay for immunological analysis of pre erythrocytic malaria vaccines
od: L. K. Stockdale, i dr.
Izdano: (2025-01-01)

Validation of a multiplexed immunoassay for immunological analysis of pre erythrocytic malaria vaccines
od: Stockdale, LK, i dr.
Izdano: (2025)

Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in a malaria endemic area.
od: Bejon, P, i dr.
Izdano: (2006)

Development of a durable and efficacious pre-erythrocytic malaria vaccine
od: Rudiansyah, I
Izdano: (2022)

Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
od: Bauza, K
Izdano: (2012)

Small cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responses.
od: Milicic, A, i dr.
Izdano: (2012)

Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus
od: Sheerin, D, i dr.
Izdano: (2022)

Acquisition and longevity of antibodies to Plasmodium vivax pre-erythrocytic antigens in western Thailand.
od: Longley, R, i dr.
Izdano: (2016)

Acquisition and longevity of antibodies to Plasmodium vivax pre-erythrocytic antigens in western Thailand
od: Longley, R, i dr.
Izdano: (2016)

Viral vectored transmission blocking vaccines against Plasmodium falciparum
od: Kapulu, M, i dr.
Izdano: (2010)

Assessment of immunogenicity and neutralisation efficacy of viral-vectored vaccines against Chikungunya virus
od: López-Camacho, C, i dr.
Izdano: (2019)